Growing Market Presence Tasso is expanding its footprint across healthcare systems, clinical research organizations, academic medical centers, and sports organizations, presenting multiple opportunities to offer at-home diagnostic solutions tailored to diverse industry needs.

Strategic Partnerships Recent collaborations with ARUP, Neurogen, SheMed, and SNBL demonstrate a strong trend toward integrating Tasso's blood testing technology into clinical trials, brain health ecosystems, and patient-centric care, opening avenues for targeted enterprise sales.

Innovation at Major Events Participation in the 2026 Olympic Winter Games with anti-doping technology deployment positions Tasso as a leader in secure, painless testing solutions, highlighting potential sales opportunities in athletic health, anti-doping agencies, and event organizers.

Focus on Clinical Research Developing at-home blood testing services to support clinical research, with partnerships like ARUP, indicates ongoing demand from research organizations seeking efficient, remote sampling, ideal for expanding into research-focused accounts.

Funding and Growth With substantial funding of $100M and revenues between $25M and $50M, Tasso is well-positioned for accelerated sales growth, especially by showcasing its innovative blood collection technology to large healthcare and laboratory companies seeking to reduce needle phobia and improve patient compliance.